Annual CFO
-$130.36 M
-$41.14 M-46.11%
December 31, 2023
Summary
- As of February 7, 2025, ALXO annual cash flow from operations is -$130.36 million, with the most recent change of -$41.14 million (-46.11%) on December 31, 2023.
- During the last 3 years, ALXO annual CFO has fallen by -$92.08 million (-240.47%).
- ALXO annual CFO is now -888.35% below its all-time high of -$13.19 million, reached on December 31, 2018.
Performance
ALXO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$25.38 M
+$1.19 M+4.48%
September 30, 2024
Summary
- As of February 7, 2025, ALXO quarterly cash flow from operations is -$25.38 million, with the most recent change of +$1.19 million (+4.48%) on September 30, 2024.
- Over the past year, ALXO quarterly CFO has increased by +$5.78 million (+18.56%).
- ALXO quarterly CFO is now -782.95% below its all-time high of -$2.87 million, reached on December 31, 2019.
Performance
ALXO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$129.54 M
+$5.78 M+4.27%
September 30, 2024
Summary
- As of February 7, 2025, ALXO TTM cash flow from operations is -$129.54 million, with the most recent change of +$5.78 million (+4.27%) on September 30, 2024.
- Over the past year, ALXO TTM CFO has dropped by -$18.19 million (-16.34%).
- ALXO TTM CFO is now -3255.19% below its all-time high of -$3.86 million, reached on March 31, 2019.
Performance
ALXO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ALXO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.1% | +18.6% | -16.3% |
| 3 y3 years | -240.5% | -22.7% | -54.9% |
| 5 y5 years | -888.4% | -394.2% | -275.9% |
ALXO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -91.4% | at low | -49.3% | +36.0% | -90.2% | +7.8% |
| 5 y | 5-year | -814.9% | at low | -783.0% | +36.0% | -809.1% | +7.8% |
| alltime | all time | -888.4% | at low | -783.0% | +36.0% | -3255.2% | +7.8% |
ALX Oncology Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$25.38 M(-4.5%) | -$129.54 M(-4.3%) |
| Jun 2024 | - | -$26.57 M(-29.9%) | -$135.33 M(-3.7%) |
| Mar 2024 | - | -$37.92 M(-4.4%) | -$140.47 M(+7.8%) |
| Dec 2023 | -$130.36 M(+46.1%) | -$39.68 M(+27.3%) | -$130.36 M(+17.1%) |
| Sep 2023 | - | -$31.16 M(-1.7%) | -$111.35 M(+0.2%) |
| Jun 2023 | - | -$31.71 M(+14.0%) | -$111.08 M(+15.3%) |
| Mar 2023 | - | -$27.82 M(+34.6%) | -$96.36 M(+8.0%) |
| Dec 2022 | -$89.22 M(+31.0%) | -$20.67 M(-33.1%) | -$89.22 M(+3.7%) |
| Sep 2022 | - | -$30.88 M(+81.7%) | -$86.04 M(+7.5%) |
| Jun 2022 | - | -$17.00 M(-17.8%) | -$80.02 M(-4.3%) |
| Mar 2022 | - | -$20.67 M(+18.2%) | -$83.64 M(+22.8%) |
| Dec 2021 | -$68.10 M | -$17.49 M(-29.6%) | -$68.10 M(+6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$24.86 M(+20.5%) | -$64.23 M(+31.3%) |
| Jun 2021 | - | -$20.62 M(+301.6%) | -$48.92 M(+42.0%) |
| Mar 2021 | - | -$5.13 M(-62.3%) | -$34.46 M(-10.0%) |
| Dec 2020 | -$38.29 M(+168.7%) | -$13.62 M(+42.6%) | -$38.29 M(+39.0%) |
| Sep 2020 | - | -$9.55 M(+54.9%) | -$27.55 M(+30.0%) |
| Jun 2020 | - | -$6.16 M(-31.2%) | -$21.19 M(+9.5%) |
| Mar 2020 | - | -$8.96 M(+211.9%) | -$19.35 M(+35.8%) |
| Dec 2019 | -$14.25 M(+8.0%) | -$2.87 M(-9.8%) | -$14.25 M(+25.3%) |
| Sep 2019 | - | -$3.19 M(-26.4%) | -$11.38 M(+38.9%) |
| Jun 2019 | - | -$4.33 M(+12.1%) | -$8.19 M(+112.1%) |
| Mar 2019 | - | -$3.86 M | -$3.86 M |
| Dec 2018 | -$13.19 M | - | - |
FAQ
- What is ALX Oncology Holdings annual cash flow from operations?
- What is the all time high annual CFO for ALX Oncology Holdings?
- What is ALX Oncology Holdings annual CFO year-on-year change?
- What is ALX Oncology Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for ALX Oncology Holdings?
- What is ALX Oncology Holdings quarterly CFO year-on-year change?
- What is ALX Oncology Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for ALX Oncology Holdings?
- What is ALX Oncology Holdings TTM CFO year-on-year change?
What is ALX Oncology Holdings annual cash flow from operations?
The current annual CFO of ALXO is -$130.36 M
What is the all time high annual CFO for ALX Oncology Holdings?
ALX Oncology Holdings all-time high annual cash flow from operations is -$13.19 M
What is ALX Oncology Holdings annual CFO year-on-year change?
Over the past year, ALXO annual cash flow from operations has changed by -$41.14 M (-46.11%)
What is ALX Oncology Holdings quarterly cash flow from operations?
The current quarterly CFO of ALXO is -$25.38 M
What is the all time high quarterly CFO for ALX Oncology Holdings?
ALX Oncology Holdings all-time high quarterly cash flow from operations is -$2.87 M
What is ALX Oncology Holdings quarterly CFO year-on-year change?
Over the past year, ALXO quarterly cash flow from operations has changed by +$5.78 M (+18.56%)
What is ALX Oncology Holdings TTM cash flow from operations?
The current TTM CFO of ALXO is -$129.54 M
What is the all time high TTM CFO for ALX Oncology Holdings?
ALX Oncology Holdings all-time high TTM cash flow from operations is -$3.86 M
What is ALX Oncology Holdings TTM CFO year-on-year change?
Over the past year, ALXO TTM cash flow from operations has changed by -$18.19 M (-16.34%)